David Drouin receives a four-year suspension for anabolic agent
In April 2017 it was announced Drouin of Saint-Prosper, Que had tested positive for SARM RAD-140
David Drouin of Saint-Prosper, Que. has received a four-year suspension from the Canadian Centre for Ethics in Sport (CCES). Drouin tested positive for the banned anabolic agent SARM RAD-140 during an out of competition doping control in Dec. 2016.
The 22-year-old rose to prominence in 2016 with strong results throughout the season. Racing for the Canadian national team, he was 10th overall in the Tour de Beauce. Near the end of July 2016, he joined Silber Pro Cycling as a stagiaire. The team took him to the Tour of Utah and the Tour of Alberta where he finished 31st and 54th overall, respectively. The climber also rode with some of world’s best riders in the Grands Prix Cyclistes de Québec et de Montréal, again with the Canadian squad. In October, he competed in the under-23 world championship road race in Doha, finishing with the winning bunch in 42nd place.
Drouin had a contract to race with Silber in 2017, which was to start January 1. Drouin notified the team of the failed test shortly after he found out. His contract was soon annulled.
In response to the failed doping test in a urine sample from Dec. 4, 2016, Drouin admitted the anti-doping rule violation but proceeded to argue that it occurred accidentally from drinking from a contaminated water bottle stored in a fridge which his brother used. In their testimony, Drouin’s brother Jean-Philippe admitted to using SARM RAD-140 for bodybuilding. Medical testimony put this claim in doubt as the concentration of the banned substance was too high to have been from a contaminated bottle.
Arbitrator Patrice Brunet imposed a suspension of four years ineligibility from sport which will terminate January 25, 2021. Drouin filed an unsuccessful appeal with the Canadian Anti-Doping Program (CADP) and will be prohibited from participating in any sport affiliated with CADP including training with teammates.
